Search

Your search keyword '"Rix, Uwe"' showing total 8 results
Start Over Author "Rix, Uwe" Journal blood
8 results on '"Rix, Uwe"'

3. Further Evaluation of Pro-Atherogenic and Anti-Angiogenic Effects of Nilotinib in Mice and in Patients with Ph-Chromosome+ CML

Author

Hadzijusufovic, Emir, primary, Albrecht-Schgoer, Karin, additional, Huber, Kilian, additional, Grebien, Florian, additional, Eisenwort, Gregor, additional, Schgoer, Wilfried, additional, Kaun, Christoph, additional, Herndlhofer, Susanne, additional, Theurl, Markus, additional, Cerny-Reiterer, Sabine, additional, Hoermann, Gregor, additional, Sperr, Wolfgang R, additional, Rix, Uwe, additional, Sadovnik, Irina, additional, Jilma, Bernd, additional, Schernthaner, Gerit Holger, additional, Wojta, Johann, additional, Wolf, Dominik, additional, Superti-Furga, Giulio, additional, Kirchmair, Rudolf, additional, and Valent, Peter, additional

Published
2014
Full Text
View/download PDF

4. KIT-D816V–independent oncogenic signaling in neoplastic cells in systemic mastocytosis: role of Lyn and Btk activation and disruption by dasatinib and bosutinib

Author

Gleixner, Karoline V., primary, Mayerhofer, Matthias, additional, Cerny-Reiterer, Sabine, additional, Hörmann, Gregor, additional, Rix, Uwe, additional, Bennett, Keiryn L., additional, Hadzijusufovic, Emir, additional, Meyer, Renata A., additional, Pickl, Winfried F., additional, Gotlib, Jason, additional, Horny, Hans-Peter, additional, Reiter, Andreas, additional, Mitterbauer-Hohendanner, Gerlinde, additional, Superti-Furga, Giulio, additional, and Valent, Peter, additional

Published
2011
Full Text
View/download PDF

5. Effects of Bosutinib (SKI-606) in CML: Kinase Target Profile, Effects on BCR/ABL Mutants, and Synergism with Dasatinib in T315I+ Cells

Author

Gleixner, Karoline Veronika, primary, Rix, Lily L Remsing, primary, Baumgartner, Christian, primary, Rix, Uwe, primary, Gruze, Alexander, primary, Meyer, Renata Anna, primary, Pickl, Winfried F., primary, Sillaber, Christian, primary, Augustin, Martin, primary, Till, Jeff, primary, Superti-Furga, Giulio, primary, and Valent, Peter, primary

Published
2008
Full Text
View/download PDF

6. Chemical proteomic profiles of the BCR-ABL inhibitors imatinib, nilotinib, and dasatinib reveal novel kinase and nonkinase targets

Author

Rix, Uwe, primary, Hantschel, Oliver, additional, Dürnberger, Gerhard, additional, Remsing Rix, Lily L., additional, Planyavsky, Melanie, additional, Fernbach, Nora V., additional, Kaupe, Ines, additional, Bennett, Keiryn L., additional, Valent, Peter, additional, Colinge, Jacques, additional, Köcher, Thomas, additional, and Superti-Furga, Giulio, additional

Published
2007
Full Text
View/download PDF

8. Delineation of a KIT-Independent Oncogenic Pathway in Neoplastic Mast Cells That Involves Lyn and Btk, and Can Be Disrupted by the KIT/Lyn/Btk-Targeting Drug Dasatinib

Author

Gleixner, Karoline V., primary, Mayerhofer, Matthias, primary, Rix, Uwe, primary, Hoermann, Gregor, primary, Gruze, Alexander, primary, Krauth, Maria-Theresa, primary, Pickl, Winfried F., primary, Sillaber, Christian, primary, Superti-Furga, Giulio, primary, and Valent, Peter, primary

Published
2007
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results